Radioprotection News and Articles

Return to Library

Recent Radioprotection News and Articles

• Findings in Thyroid Cancer Reported from University of Rome
• Scientists at Beckman Research Institute Release New Data on Prostate Cancer
• New Radiation Research Study Findings Have Been Reported by C. Metz-Flamant and Co-Researchers
• Research from University of California School of Medicine in the Area of Reactive Oxygen Species Described
• Studies from Mount Sinai School of Medicine Describe New Findings in Biotherapies and Radiopharmaceuticals
• Reports on Biomedicine Findings from University of Connecticut Provide New Insights
• New Toxicology and Applied Pharmacology Study Results from Bhabha Atomic Research Centre Described
• Researchers from Uniformed Services University of the Health Sciences Discuss Findings in Apoptosis

---

New Apoptosis Research from Uniformed Services University of the Health Sciences Outlined

2012 NOV 14 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- New research on Apoptosis is the subject of a report. According to news reporting originating in Bethesda, Maryland, by NewsRx journalists, research stated, "Objective The objective of this study was to investigate the correlation between in vivo d-tocotrienol (DT3) pharmacokinetics, pharmacodynamics and radiation protection, and to evaluate the effect of DT3 pre-treatment on radiation-induced alterations in apoptotic and autophagic pathways. We evaluated pharmacokinetics (plasma, 0.5 to 12 h) and pharmacodynamics (peripheral blood indices; day 3, 7, 10 and 14) after a single subcutaneous injection of 300 mg kg(-1) DT3 in unirradiated CD2F1 mice."

The news reporters obtained a quote from the research from the Uniformed Services University of the Health Sciences, "Next, we monitored 30-day post-irradiation survival (9.25 Gy) and haematopoietic recovery of DT3-treated mice (7 Gy) exposed to cobalt-60 '-irradiation. The effects of DT3 on irradiated bone marrow apoptosis and autophagy were determined by analyses of key caspases (3, 7, 9 and 8), beclin-1 and light chain 3 conversion. Plasma concentration of DT3 reached ~195 M (Cmax) 1 h after injection (Tmax), and DT3 was eliminated from plasma 12 h later. In unirradiated mice, DT3 significantly increased white blood cells (WBCs), neutrophils, lymphocytes (day 3 post DT3 injection) and platelets (day 7) by 1.5-to 2-fold, over vehicle-treated control. DT3 pre-treatment improved 30-day survival to 100% (~15% in control) and accelerated recovery of reticulocytes, platelets, WBCs, neutrophils, lymphocytes and monocytes in peripheral blood. DT3 reduced activation of caspase-8, caspase-3 and caspase-7, inherent to apoptosis, while increasing autophagy-related beclin-1 expression in irradiated bone marrow. These data indicate that DT3 stimulates multilineage haematopoiesis, protects against radiation-induced apoptosis downstream of the mitochondria and stimulates cytoprotective autophagy."

According to the news reporters, the research concluded: "Apart from a potent antioxidant activity, DT3 may elicit survival advantage following irradiation by enhancing haematopoiesis and modulating signalling pathways."

For more information on this research see: Mechanism of radioprotection by d-tocotrienol: pharmacokinetics, pharmacodynamics and modulation of signalling pathways. The British Journal of Radiology, 2012;85(1019):e1093-103.

Our news correspondents report that additional information may be obtained by contacting M. Satyamitra, Armed Forces Radiobiology Research Institute (AFRRI), Uniformed Services University of the Health Sciences, Bethesda, MD, United States.

Keywords for this news article include: Pharmaceuticals, Drugs, Therapy, Bethesda, Maryland, Caspases, Apoptosis, United States, Pharmacokinetics, Peptide Hydrolases, Enzymes and Coenzymes, Cysteine Endopeptidases, North and Central America.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2012, NewsRx LLC